Cloning, ligation and expression of the variable region genes of the monoclonal antibody against human HnRNPA2/B1

Chinese Journal of Medical Genetics

Volumn 21, Issue 6, 2004, Pages 548-551

  Wang, Xia ^a   Peng, Xiao Dong ^b   Li, Guang ^a   Hu, Li Juan ^a   Bi, Jian Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Heterogeneous nuclear ribonucleoprotein A2 B1; Lung cancer; Single chain Fv; Variable region genes of antibody

Indexed keywords

GENE PRODUCT; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HUMAN HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; PROTEIN SCFV; RIBONUCLEOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL; CELL INCLUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG CANCER; MOLECULAR CLONING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CLONING, MOLECULAR; ESCHERICHIA COLI; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LUNG NEOPLASMS;

ESCHERICHIA COLI; VECTORS;

EID: 10644272750     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Fielding P, Turnbull I, Prime W, et al. Heterogenous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer deletion. Clin Cancer Res, 1999, 5: 4048-4052.
2. Figini M, Ferri R, Mezzanzanica D, et al. Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies. Gene Therapy, 2003, 10: 1018-1025.
3. Yang ZH. Engineering antibody technique. In: Dong ZW, Wang Y. eds. Antibody engineering. 2nd ed. Beijing: Beijing Medical University Publishing House, 2002, 308-329.
4. Mulshine JL, De Luca LM, Dedrick RL, et al. Considerations in developing successful, population-based molecular screening and prevention of lung cancer. Cancer, 2000, 89: 2465-2467.
5. Man YG, Martinez A, Avis IM, et al. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alteration. Am J Respir Cell Mol Biol, 2000, 23: 636-645.
6. Kamma H, Fujimoto M, Fujiwara M, et al. Interaction of hnRNP A2/B1 isoforms with Telomeric ssDNA and the in vitro function. Biochem Biophys Res Commun, 2001, 280: 625-630.
7. Irene P, Ruben P, Gemma T, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer, 2003, 41: 131-143.